Ellie Collins
A new, dedicated Informatics and Data Science Practice is poised to optimize data insights for Oxford PharmaGenesis clients. The practice builds on more than 20 years of in-house experience, and will take advantage of the growing and evolving volume of biomedical data sources within healthcare.
Read More
Over the weekend of 12–13 June 2021, Oxford PharmaGenesis Chief Executive Officer Chris Winchester walked 65 km from Stratford-upon-Avon to central Birmingham, raising £450 for children’s tutoring charity Jacari. To celebrate its sixty-fifth anniversary, the award-winning children’s charity Jacari has challenged its supporters to run, walk, cycle or swim 65 km in 65 days to help raise […]
Read More
Oxford PharmaGenesis has joined the Sobell Business Club, opening up new opportunities to engage with Oxfordshire’s exceptional Sobell House Hospice and the local community. This follows Oxford PharmaGenesis’s fundraising in partnership with the Rotary Club of Oxford North during our Chairman Graham Shelton’s time as Rotary Club President in 2020–21. Sobell House provides specialist palliative […]
Read More
Media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in the latest Agency 100 – the annual definitive ‘who’s who’ ranking of the sector’s top healthcare marketing firms in North America.
Read More
Oxford PharmaGenesis is helping to raise public awareness of the importance of patient diversity in clinical trials through a campaign partnership with the non-profit organization Center for Information and Study on Clinical Research Participation (CISCRP).
Read More
Oxford PharmaGenesis continues to boost colleagues’ skills and expertise through a wide range of professional and personal development sessions offered to celebrate Learning at Work Week 2021 (17–23 May).
Read More
Monday 10 May to Wednesday 12 May A focus of the 2021 Clinical Data Disclosure, Transparency and Plain Language Summaries virtual conference was on the forthcoming implementation of the EU Clinical Trial Regulation (EU CTR) and the launch of the Clinical Trial Information Service (CTIS). However, the important role of different forms of plain language […]
Read More
Oxford PharmaGenesis is delighted to have supported the publication of a Delphi consensus manuscript in the Journal of the American Society of Nephrology. The publication highlights the need to increase awareness among key stakeholders of racial health disparities in kidney disease and of APOL1-associated nephropathy.
Read More
Oxford PharmaGenesis has made its first appointments to the new role of Director of Innovation, created specifically to support teams across the global organization in utilizing new and emerging technology to support their clients’ unmet needs.
Read More
Oxford PharmaGenesis has been designated a centre of Excellence in Wellbeing this year by Great Place to Work®. The accolade recognizes organizations with excellent well-being practices and is a welcome acknowledgement of our increasing efforts to foster a culture of openness, empowerment and support in the workplace.
Read More